< Back to latest news & events

Event

Manufacturing & Supply Chain Conference 2022

February 2022

Event date: 10th March 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK.

The Manufacturing & Supply Chain Conference is a national forum for manufacturers and operators involved throughout the associated supply chains from across the UK. It is an opportunity to gather to discuss pressing issues facing the industry.

The event will cover various topical themes including: Industry 4.0, Digital Manufacturing, Smart Factory, Lean & Continuous Improvement, Robotics & Automation, Financing Investment, Industrial Blockchain, Research & Development, Precision Engineering, QEHS, Supply Chain & Logistics, Sustainability, Government Policy and Industrial Strategy, Exports and Skills & Training.

Dr Robert Weinert-Aplin will be speaking on ‘Is 3D printing changing the status quo for manufacturers and the supply chain?‘:

Additive manufacturing (AM) has advanced hugely over the last decade, and is benefiting a wider range of industries. Improvements in AM technologies has enabled companies to move from seeing AM solely as a prototyping tool to having AM processes embedded within the manufacturing and supply chains of the final product to provide more sustainable products with shorter lead times that were previously not economically viable. Traditionally, registered intellectual property rights (IPRs), particularly patents, would underpin a company’s decision to invest in new technology to change the status quo. However, the laws related to IPRs have arguably not adapted at the same pace as the technology they aim to protect. While new materials and manufacturing methods specific to AM sit comfortably within the patent system, the Computer-Aided Design (CAD) models which underpin the AM processes are at risk of falling outside the scope of the existing IPR regimes. In this talk, Rob discusses how AM is changing a product’s value chain and how IPRs can be used to protect your investment when incorporating AM processes into manufacturing and supply chains.

Latest updates

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details